HPST — Hempstract Share Price
Last trade - 00:00- $2.60m
- $3.12m
- $10.31m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.32 | ||
| Price to Tang. Book | 0.32 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.15 | ||
| EV to EBITDA | 2.09 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 18.17% | ||
| Return on Equity | 40.16% | ||
| Operating Margin | 8.64% | ||
Financial Summary
| Year End 31st Dec | Unit | 2008 | 2009 | 2010 | 2011 | 2012 | 2013E | 2014E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 11.48 | 12.32 | 14.05 | 8.45 | 10.31 | n/a | n/a | -2.64% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Hempstract, Inc. is engaged in developing and selling hemp-based products. The Company is focused on offering premium cannabidiol (CBD) solutions. The Company is also focused on the process of renovating the ICBM Titan Missile facility site in eastern Washington state to produce quality THC-Free products that are derived from non-genetically modified organisms (GMO) industrial hemp grown with natural farming practices. Its products include CBD isolate and distillate oil, nutritional whole plant extract for topicals, lotions, bath bombs, pills and pet products. In addition, the Company has also developed formulations and applications for CBD and related cannabinoids.
Directors
- Address
- 251 Jeanell Dr Ste 3, CARSON CITY, 89703
- Web
- http://www.rvdoil.com/
- Phone
- +1 5126871114
- Auditors
- Stonefield & Josephson
Similar to HPST
1st NRG
Pink Sheets on Nasdaq
Abby
Pink Sheets on Nasdaq
Able Energy
Pink Sheets on Nasdaq
Action Energy
Pink Sheets on Nasdaq
Advantage Energy
Pink Sheets on Nasdaq
FAQ
As of Today at 21:06 UTC, shares in Hempstract are trading at $0.00. This share price information is delayed by 15 minutes.
Shares in Hempstract last closed at $0.00 and the price had moved by +27.78% over the past 365 days. In terms of relative price strength the Hempstract share price has outperformed the S&P500 Index by +7.24% over the past year.
There is no consensus recommendation for this security.
Hempstract does not currently pay a dividend.
Hempstract does not currently pay a dividend.
Hempstract does not currently pay a dividend.
To buy shares in Hempstract you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.00, shares in Hempstract had a market capitalisation of $2.90m.
Here are the trading details for Hempstract:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: HPST
Based on an overall assessment of its quality, value and momentum Hempstract is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Hempstract. Over the past six months, its share price has underperformed the S&P500 Index by -7.43%.
As of the last closing price of $0.00, shares in Hempstract were trading -42.69% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Hempstract PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Hempstract's management team is headed by:
- Ron Herzfeld - PRE
- Linda Ellis - VPR
- Michael Glazer - SEC